Short-term treatment of iron deficiency anemia after cardiac surgery.
Cardiac surgery
Exercise capacity
Ferric carboxymaltose
Iron deficiency anemia
Sucrosomial iron
Journal
International journal of cardiology. Heart & vasculature
ISSN: 2352-9067
Titre abrégé: Int J Cardiol Heart Vasc
Pays: Ireland
ID NLM: 101649525
Informations de publication
Date de publication:
Jun 2022
Jun 2022
Historique:
received:
08
02
2022
revised:
18
04
2022
accepted:
21
04
2022
entrez:
6
5
2022
pubmed:
7
5
2022
medline:
7
5
2022
Statut:
epublish
Résumé
Iron deficiency anemia (IDA) is frequent after cardiac surgery and is associated with increased morbidity and mortality. In a retrospective study, we analyzed 106 patients with IDA (hemoglobin [Hb] ≤ 12 g/dl in women and ≤ 13 g/dl in men, transferrin saturation [TSAT] ≤ 20%) on admission to a Cardiac Rehabilitation Unit after cardiac surgery. The patients were divided into two groups, one was treated with oral sucrosomial iron (SI) and the other with intravenous ferric carboxymaltose (FCM). Patients received a single 1000 mg dose of FCM from the day after admission to rehabilitation (T1), or a 120 mg/day dose of SI from T1 until discharge (T2); after discharge, SI was reduced to 30 mg/day until the end of follow-up (T3). Hb was evaluated at T1, T2 and T3; the other hematological parameters at T1 and T3; natriuretic peptides at T1, T2 and T3; 6-minute walk test (6MWT) at T1 and T2. Folate, vitamin B12 and reticulocytes were sampled on admission. Folate deficiency was documented in 60.4% of patients. Hb increased in both groups with no significant differences between the two treatments (p = 0.397). The other iron metabolism parameters (sideremia, transferrin, TSAT) displayed similar behavior, showing a significant increase at T3 (p < 0.001) with both therapies, although the increase was faster with FCM. Ferritin - high on admission - decreased at T3 in the SI group and rose significantly in the FCM group (SI 219.5 vs. FCM 689 ng/ml p < 0.0001). The 6MWT increased significantly at T2, with an overlap between SI and FCM. In conclusion, the results of this study show that SI and FCM exhibit the same effectiveness on IDA; the response time to therapy of both treatments is also equally fast. SI and FCM induce a similar increase in functional capacity. The study shows that SI can be a viable alternative to FCM after cardiac surgery in terms of effectiveness and tolerability.
Identifiants
pubmed: 35514874
doi: 10.1016/j.ijcha.2022.101038
pii: S2352-9067(22)00087-2
pmc: PMC9066354
doi:
Types de publication
Journal Article
Langues
eng
Pagination
101038Informations de copyright
© 2022 The Author(s).
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
J Am Coll Cardiol. 2018 May 15;71(19):2270-2271
pubmed: 29747838
Eur J Heart Fail. 2021 Apr;23(4):598-600
pubmed: 33786958
Monaldi Arch Chest Dis. 2020 Mar 03;90(1):
pubmed: 32124586
Eur J Pharm Sci. 2018 Jan 1;111:425-431
pubmed: 29055735
Interact Cardiovasc Thorac Surg. 2012 Dec;15(6):1013-8
pubmed: 22940889
Metallomics. 2014 Apr;6(4):748-73
pubmed: 24549403
N Engl J Med. 2019 Jan 31;380(5):447-458
pubmed: 30365356
Ann Hematol. 2021 Sep;100(9):2173-2179
pubmed: 33263170
J Cardiothorac Surg. 2014 Aug 05;9:137
pubmed: 25096231
Biomolecules. 2018 Jul 20;8(3):
pubmed: 30037035
J Am Coll Cardiol. 2007 Oct 23;50(17):1657-65
pubmed: 17950147
J Nutr. 2001 Feb;131(2S-2):565S-567S
pubmed: 11160589
Eur Heart J. 2015 Mar 14;36(11):657-68
pubmed: 25176939
J Am Coll Cardiol. 2008 Jan 15;51(2):103-12
pubmed: 18191732
Lancet. 2020 Dec 12;396(10266):1895-1904
pubmed: 33197395
Pulm Circ. 2015 Sep;5(3):466-72
pubmed: 26401247
Monaldi Arch Chest Dis. 2020 Feb 06;90(1):
pubmed: 32072798
Eur Heart J. 2021 Aug 17;42(31):3021-3022
pubmed: 34131705
Clin Res Cardiol. 2020 Nov;109(11):1352-1357
pubmed: 32215702
Anaesthesia. 2018 Nov;73(11):1418-1431
pubmed: 30062700
Eur J Heart Fail. 2021 Apr;23(4):593-597
pubmed: 33421230
J Extra Corpor Technol. 2021 Jun;53(2):97-124
pubmed: 34194077
Br J Anaesth. 2020 Jan;124(1):25-34
pubmed: 31668348
Eur J Prev Cardiol. 2017 May;24(8):799-807
pubmed: 28117617
Eur J Heart Fail. 2022 May;24(5):807-817
pubmed: 34050582
JACC Heart Fail. 2019 Jan;7(1):36-46
pubmed: 30553903
J Hematol. 2020 Dec;9(4):97-108
pubmed: 33224389
Am J Respir Crit Care Med. 2002 Jul 1;166(1):111-7
pubmed: 12091180
Circulation. 2019 May 21;139(21):2386-2398
pubmed: 30776909
Ann Thorac Surg. 2012 Oct;94(4):1134-41
pubmed: 22698773
Semin Thorac Cardiovasc Surg. 2019 Summer;31(2):157-163
pubmed: 30273647
N Engl J Med. 1999 Dec 23;341(26):1986-95
pubmed: 10607817
Eur Heart J. 2021 Dec 21;42(48):4905-4914
pubmed: 34185066
Eur J Heart Fail. 2018 Jan;20(1):125-133
pubmed: 28436136
Lancet. 2019 Jun 1;393(10187):2201-2212
pubmed: 31036337
Int J Mol Sci. 2018 Sep 12;19(9):
pubmed: 30213039
Surg Technol Int. 2021 Oct 28;39:321-328
pubmed: 34710946
Acta Cardiol. 2018 Apr;73(2):115-123
pubmed: 28730869
Am Heart J. 2006 Jun;151(6):1247.e1-7
pubmed: 16781229
Circulation. 2008 Jan 29;117(4):478-84
pubmed: 18172032
Circulation. 2007 Nov 27;116(22):2544-52
pubmed: 17998460
Heart. 2015 Jan;101(2):107-12
pubmed: 25217489
JAMA. 2017 May 16;317(19):1958-1966
pubmed: 28510680
JAMA. 2020 Feb 4;323(5):432-443
pubmed: 32016310
Nutrients. 2021 Feb 12;13(2):
pubmed: 33673371
JAMA Cardiol. 2016 Aug 1;1(5):539-47
pubmed: 27439011
N Engl J Med. 2009 Dec 17;361(25):2436-48
pubmed: 19920054
Science. 2004 Dec 17;306(5704):2090-3
pubmed: 15514116
Transfus Med Hemother. 2018 Jan;45(1):42-46
pubmed: 29593459
Clin Res Cardiol. 2021 Aug;110(8):1299-1307
pubmed: 33755777
Blood Adv. 2020 Aug 11;4(15):3639-3647
pubmed: 32766854
Eur J Heart Fail. 2014 Sep;16(9):984-91
pubmed: 25065368
J Am Heart Assoc. 2020 May 5;9(9):e015480
pubmed: 32321351
Circulation. 2017 Oct 10;136(15):1374-1383
pubmed: 28701470
Circulation. 2018 Jul 3;138(1):80-98
pubmed: 29967232
Eur J Heart Fail. 2018 May;20(5):910-919
pubmed: 29484788
Am J Perinatol. 2019 Mar;36(4):366-376
pubmed: 30121943